Hepatocellular Carcinoma Risk After Hepatitis C Cure

Opinion statementWith the recent introduction of direct acting antiviral agents for hepatitis C treatment, many patients are receiving these highly effective therapies. Patients with advanced fibrosis or cirrhosis prior to antiviral treatment will have decreased but persistent risk of hepatocellular carcinoma following cure of hepatitis C. This review will discuss this risk and review current surveillance recommendations.
Source: Current Treatment Options in Infectious Diseases - Category: Infectious Diseases Source Type: research